Eisai tender offer for MGI Pharma to end Jan. 22

By Lisa Kerner

Charlotte, N.C., Dec. 21 - Eisai Co., Ltd. subsidiary Jaguar Acquisition Corp. began its $41-per-share cash tender offer for all outstanding shares of MGI Pharma, Inc. common stock.

The tender offer will end at midnight ET on Jan. 22 unless extended, according to a company news release.

Computershare Trust Co., NA is the depositary, and J.P. Morgan Securities Inc. is the dealer manager for the offer. The information agent is Georgeson Inc.

As previously reported, Eisai agreed to acquire MGI Pharma in an all-cash transaction valued at about $3.9 billion.

MGI Pharma is a Bloomington, Minn., biopharmaceutical company.

Eisai is a research-based human health care company based in Tokyo.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.